PF-03654764
CAS No. 935840-35-0
PF-03654764 ( PF 3654764 )
Catalog No. M16695 CAS No. 935840-35-0
PF-03654764 (PF 3654764) is a potent, selective, orally bioactive antagonist of H3 receptor with Ki of 1.4 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
10MG | 1137 | Get Quote |
|
25MG | 1945 | Get Quote |
|
100MG | Get Quote | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NamePF-03654764
-
NoteResearch use only, not for human use.
-
Brief DescriptionPF-03654764 (PF 3654764) is a potent, selective, orally bioactive antagonist of H3 receptor with Ki of 1.4 nM.
-
DescriptionPF-03654764 (PF 3654764) is a potent, selective, orally bioactive antagonist of H3 receptor with Ki of 1.4 nM; displays >1000-fold selectivity versus H1, H2, H4 and other GPCRs (IC50>10 uM); possesses optimal pharmacological and pharmacokinetic profiles, shows potential in allergen-induced nasal symptoms. Allergy Phase 2 Discontinued
-
SynonymsPF 3654764
-
PathwayGPCR/G Protein
-
TargetHistamine Receptor
-
RecptorHistamine Receptor
-
Research AreaInflammation/Immunology
-
IndicationAllergy
Chemical Information
-
CAS Number935840-35-0
-
Formula Weight322.45
-
Molecular FormulaC18H24F2N2O
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC(C)CNC(=O)C1CC(C1)(C2=CC(=C(C=C2)CN3CCCC3)F)F
-
Chemical NameTrans-3-fluoro-3-[3-fluoro-4-(pyrrolidin-1-ylmethyl)phenyl]-N-(2-methylpropyl)cyclobutanecarboxamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Wager TT, et al. J Med Chem. 2011 Nov 10;54(21):7602-20.
2. North ML, et al. Allergy Asthma Clin Immunol. 2014 Jul 3;10(1):33.
2. North ML, et al. Allergy Asthma Clin Immunol. 2014 Jul 3;10(1):33.
molnova catalog
related products
-
Diphenhydramine
Diphenhydramine, a first-generation antihistamine possessing antiemetic, antitussive, anticholinergic, and sedative properties, is mainly used in the treatment of allergies.
-
Astemizole
Astemizole (R 43512), a second-generation antihistamine drug to diminish allergic symptoms with a long duration of action, is a histamine H1-receptor antagonist, with an IC50 of 4 nM.
-
Cetirizine dihydroch...
A second-generation antihistamine that acts as a selective H1 receptor antagonist.